CARM — CARISMA THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-31 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 1 SEC-registered investment managers reported holding CARM (CARISMA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $4 across 785 shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved -81.8%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CARISMA THERAPEUTICS INC (CARM) include TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, TPG GP A, LLC, AJU IB Investment Co., Ltd., ranked by reported 13F value among the 105 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2026 | 1 | 785 | $4 | +0.0% |
| Q1 2026 | 3 | 1.47M | $47.91K | +0.0% |
| Q4 2025 | 6 | 1.56M | $66.96K | +0.0% |
| Q3 2025 | 32 | 3.12M | $854.40K | -1.4% |
| Q2 2025 | 36 | 4.02M | $1.57M | -29.3% |
| Q1 2025 | 37 | 5.61M | $1.74M | -0.8% |
| Q4 2024 | 42 | 5.78M | $2.42M | -0.8% |
| Q3 2024 | 38 | 5.38M | $5.28M | +0.9% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q3 2024 → Q2 2026); the largest single-quarter swing was Q2 2025 (-29.3%).
Top Institutional Holders (Q2 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 785 | $4 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q1 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.47M | $47.88K | 0.01% | Hold | |
| 785 | $22 | 0.00% | Hold | |
| 200 | $6 | 0.00% | New |
Q4 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.47M | $63.35K | 0.02% | Hold | |
| 40.10K | $1.72K | 0.00% | New | |
| 30.99K | $1.33K | 0.00% | Hold | |
| 19.52K | $517 | 0.00% | New | |
| 785 | $28 | 0.00% | Add | |
| 206 | $9 | 0.00% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.47M | $403.67K | 0.18% | Hold | |
| 350.32K | $95.99K | 0.00% | Hold | |
| 336.79K | $92.28K | 0.00% | Hold | |
| 293.69K | $80.47K | 0.00% | Reduce | |
| 250.50K | $68.65K | 0.00% | Hold | |
| 85.11K | $23.32K | 0.00% | Hold | |
| 55.04K | $15.08K | 0.00% | Hold | |
| 50.12K | $13.73K | 0.00% | Hold | |
| 43.30K | $11.86K | 0.00% | Add | |
| 30.99K | $8.49K | 0.00% | Hold | |
| 30.99K | $8.49K | 0.00% | Hold | |
| 24.00K | $6.58K | 0.01% | Hold | |
| 22.85K | $6.00K | 0.00% | New | |
| 16.41K | $4.50K | 0.00% | Add | |
| 15.35K | $4.21K | 0.00% | Hold | |
| 12.83K | $3.52K | 0.00% | Reduce | |
| 11.27K | $3.09K | 0.00% | New | |
| 7.03K | $1.93K | 0.00% | Reduce | |
| 3.19K | $873 | 0.00% | Hold | |
| 2.23K | $611 | 0.00% | Hold | |
| 1.40K | $383 | 0.00% | Add | |
| 921 | $252 | 0.00% | Hold | |
| 535 | $131 | 0.00% | Hold | |
| 347 | $95 | 0.00% | Hold | |
| 206 | $56 | 0.00% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.47M | $576.92K | 0.27% | Hold | |
| 718.33K | $281.30K | 0.31% | Hold | |
| 350.32K | $137.33K | 0.00% | Reduce | |
| 336.79K | $131.89K | 0.00% | Reduce | |
| 329.29K | $128.95K | 0.00% | Add | |
| 250.50K | $98.11K | 0.00% | Add | |
| 150.81K | $59.06K | 0.00% | New | |
| 85.11K | $33.33K | 0.00% | Hold | |
| 55.04K | $21.55K | 0.00% | Hold | |
| 50.12K | $19.65K | 0.00% | New | |
| 34.80K | $13.63K | 0.00% | Add | |
| 30.99K | $12.13K | 0.00% | Hold | |
| 30.99K | $12.13K | 0.00% | Hold | |
| 24.00K | $9.40K | 0.01% | Hold | |
| 22.11K | $8.66K | 0.00% | Add | |
| 17.95K | $7.03K | 0.00% | Add | |
| 15.35K | $6.01K | 0.01% | Hold | |
| 13.03K | $5.10K | 0.00% | New | |
| 18.40K | $4.45K | 0.00% | New | |
| 3.19K | $1.25K | 0.00% | Reduce | |
| 2.23K | $873 | 0.00% | Hold | |
| 1.33K | $522 | 0.00% | Reduce | |
| 921 | $361 | 0.00% | Reduce | |
| 525 | $206 | 0.00% | Hold | |
| 535 | $190 | 0.00% | Hold |
Q1 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.47M | $456.70K | 0.28% | Hold | |
| 1.40M | $432.64K | 0.00% | Reduce | |
| 718.33K | $222.68K | 0.27% | Hold | |
| 549.30K | $170.28K | 0.00% | Hold | |
| 406.88K | $126.13K | 0.00% | Hold | |
| 253.66K | $78.63K | 0.00% | Add | |
| 244.34K | $75.76K | 0.00% | Reduce | |
| 200.00K | $62.00K | 0.00% | New | |
| 85.11K | $26.38K | 0.00% | Hold | |
| 55.04K | $17.06K | 0.00% | Reduce | |
| 34.05K | $10.56K | 0.00% | Reduce | |
| 30.99K | $9.61K | 0.00% | Hold | |
| 30.99K | $9.61K | 0.00% | Hold | |
| 24.00K | $7.44K | 0.01% | Hold | |
| 22.20K | $6.88K | 0.00% | Add | |
| 20.89K | $6.48K | 0.00% | Hold | |
| 15.35K | $4.76K | 0.01% | Hold | |
| 11.61K | $3.60K | 0.00% | Add | |
| 10.73K | $3.33K | 0.00% | New | |
| 7.29K | $2.26K | 0.00% | Hold | |
| 5.68K | $1.76K | 0.00% | Hold | |
| 5.63K | $1.75K | 0.00% | Add | |
| 3.08K | $954 | 0.00% | Reduce | |
| 2.23K | $691 | 0.00% | Hold | |
| 948 | $294 | 0.00% | Add |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Merck & Co., Inc. sold 1.47M sh · $47.88K
- Ascentis Independent Advisors sold 200 sh · $6
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | 785 | 785 | 785 | 535 | 535 | 535 | 535 | — | — | — | — | — | — | — |
| TPG GP A, LLC | — | — | — | — | — | — | — | 561.44K | 842.03K | 1.45M | 1.68M | 1.68M | — | — |
| Vanguard Group | — | — | — | 350.32K | 350.32K | 1.40M | 1.42M | 1.45M | 1.45M | 1.58M | 1.57M | 1.56M | 1.51M | 565.72K |
| Geode Capital Management | — | — | — | 250.50K | 250.50K | 244.34K | 259.18K | 259.18K | 283.41K | 528.59K | 515.89K | 503.79K | 540.00K | 118.70K |
| STATE STREET CORP | — | — | — | 85.11K | 85.11K | 85.11K | 85.11K | 85.11K | 85.11K | 525.11K | 500.31K | 482.12K | — | — |
| Northern Trust Corp | — | — | — | 55.04K | 55.04K | 55.04K | 69.89K | 75.45K | 224.36K | 220.90K | 238.92K | 197.27K | 218.38K | 16.40K |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | — | — | — | — | — | — | — | 1.25M | — | — | — | — | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | — | — | — | 30.99K | 30.99K | 30.99K | 30.99K | 30.44K | 28.96K | 214.88K | 311.03K | 203.81K | — | — |
| Renaissance Technologies | — | — | — | 293.69K | 329.29K | 253.66K | 231.36K | 206.76K | 139.36K | 226.00K | 213.03K | 204.69K | 101.76K | 68.30K |
| Arrowstreet Capital | — | — | — | — | — | — | — | — | — | 40.60K | 45.98K | 179.58K | — | — |
| Merck & Co., Inc. | — | 1.47M | 1.47M | 1.47M | 1.47M | 1.47M | 1.47M | — | — | — | — | — | — | — |
| BARCLAYS PLC | — | — | — | — | 100 | 549.30K | 549.30K | 549.30K | 15 | 18.67K | 36.60K | 4.87K | — | — |
| BlackRock Inc | — | — | — | 336.79K | 336.79K | 406.88K | 408.15K | 408.56K | — | — | — | — | — | — |
| BNY Mellon | — | — | — | — | — | — | — | — | — | 77.71K | 83.53K | 83.75K | 84.07K | — |
| Goldman Sachs Group | — | — | — | 16.41K | 13.03K | — | 21.38K | — | 232.79K | — | 10.52K | 12.75K | 27.68K | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | — | — | — | — | — | — | — | — | — | 60.95K | 72.74K | 72.74K | — | — |
| AJU IB Investment Co., Ltd. | — | — | — | — | 718.33K | 718.33K | 718.33K | — | — | — | — | — | — | — |
| WELLINGTON MANAGEMENT GROUP LLP | — | — | — | — | — | — | — | — | — | — | — | 66.04K | — | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | — | — | 120.16K | 142.52K | 160.04K | — | — | — | — | — |
| JANE STREET GROUP, LLC | — | — | — | — | 150.81K | — | — | — | 159.88K | — | — | 36.33K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CARM?
As of 2026-Q2, 1 institutional funds reported holding CARM (CARISMA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $4.
How many shares of CARM do institutions own?
13F filers reported 785 shares of CARM, worth $4 in aggregate at the end of 2026-Q2.
Is institutional ownership of CARM rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of CARM?
The largest 13F holders are TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, TPG GP A, LLC, AJU IB Investment Co., Ltd., WELLINGTON MANAGEMENT GROUP LLP, Wellington Management Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of CARISMA THERAPEUTICS INC?
The major shareholders of CARISMA THERAPEUTICS INC (CARM) by reported 13F value are TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, TPG GP A, LLC, AJU IB Investment Co., Ltd., WELLINGTON MANAGEMENT GROUP LLP, Wellington Management Group, among 105 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.